The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery

References

• Athaudaa SB, Takahashia K. Cleavage specificities of aspartic proteinases toward oxidized insulin B chain at different pH values. Protein Pept Lett 2002; 9(4)289–294
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release 1998; 52(1–2)1–16
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Fragner R. Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration. Pharm Sci 1996; 2(1)361–363
   Google Scholar
• Bernkop-Schnürch A, Apprich I. Synthesis and evaluation of a modified mucoadhesive polymer protecting from a-chymotrypsinic degradation. Int J Pharm 1997; 146(2)247–254
   Web of Science ®Google Scholar
• Bernkop-Schnürch A, Bratengeyer I, Valenta C. Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation. Int J Pharm 1997; 157(1)17–25
   Web of Science ®Google Scholar
• Bernkop-Schnürch A, Clausen AE, Hnatyszyn M. Thiolated polymers: Synthesis and in vitro evaluation of polymer-cysteamine conjugates. Int J Pharm 2001; 226(1–2)185–194
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Kast CE, Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: Thiomer/GSH systems. J Control Release 2003; 93(2)95–103
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Guggi D, Y. Thiolated chitosans: Development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 2004; 94(1)177–186
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schöffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Huck C. The use of Thiolated polymers as carrier matrix in oral peptide delivery—proof of concept. J Control Release 2005; 106(1–2)26–33
   PubMed Web of Science ®Google Scholar
• Chiche L, Heitz A, Gelly JC, Gracy J, Chau PT, Ha PT, Hernandez JF, Le-Nguyen D. Squash inhibitors: From structural motifs to macrocyclic knottins. Curr Protein Pept Sci 2004; 5(5)341–349
   PubMed Web of Science ®Google Scholar
• Clausen AE, Bernkop-Schnürch A. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci 2000; 89(10)1253–1261
   PubMed Web of Science ®Google Scholar
• Clausen AE, Bernkop-Schnürch A. Thiolated carboxymethylcellulose: In vitro evaluation of its permeation enhancing effect on peptide drugs. Eur J Pharm Biopharm 2001; 51(1)25–32
   PubMed Web of Science ®Google Scholar
• Colgrave ML, Craik DJ. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: The importance of the cyclic cystine knot. Biochemistry 2004; 43(20)5965–5975
   PubMed Web of Science ®Google Scholar
• Craik DJ, Daly NL, Waine C. The cystine knot motif in toxins and implications for drug design. Toxicon 2001; 39(1)43–60
   PubMed Web of Science ®Google Scholar
• Doggrell SA. Intrathecal ziconotide for refractory pain. Expert Opin Investig Drugs 2004; 13(7)875–877
   PubMed Web of Science ®Google Scholar
• Guggi D, Krauland AH, Bernkop-Schnürch A. Systemic peptide delivery via the stomach: In vivo evaluation of an oral dosage form for salmon calcitonin. J Control Release 2003; 92(1–2)125–135
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Jiang G, Dong J, Qi S, Feng L, Li Z, Li C. Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer. Int J Pharm 2004; 278(2)415–422
   PubMed Web of Science ®Google Scholar
• Hentz NG, Richardson JM, Sportsman JR, Daijo J, Sittampalam GS. Synthesis and characterization of insulin-fluorescein derivatives for bioanalytical applications. Anal Chem 1997; 69(24)4994–5000
   PubMed Web of Science ®Google Scholar
• Jackson PJ, McNulty JC, Yang YK, Thompson DA, Chai B, Gantz I, Barsh GS, Millhauser GL. Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity. Biochemistry 2002; 41(24)7565–7572
   PubMed Web of Science ®Google Scholar
• Krauland AH, Guggi D, Bernkop-Schnürch A. Oral insulin delivery: The potential of thiolated chitosan-insulin tablets on non-diabetic rats. J Control Release 2004; 95(3)547–555
   PubMed Web of Science ®Google Scholar
• Nourse A, Trabi M, Daly NL, Craik DJ. A comparison of the self-association behavior of the plant cyclotides kalata B1 and kalata B2 via analytical ultracentrifugation. J Biol Chem 2003; 279(1)562–570
   PubMed Web of Science ®Google Scholar
• Pantzar N, Lundin S, Wester L, Westrom BR. Bidirectional small-intestinal permeability in the rat to some common marker molecules in vitro. Scand J Gastroenterol 1994; 29(8)703–709
   PubMed Web of Science ®Google Scholar
• Roumi M, Kwong E, Deghenghi R, Locatelli V, Marleau S, Du SP, Beliveau R, Ong H. Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum. Peptides 2001; 22(7)1129–1138
   PubMed Web of Science ®Google Scholar
• Sinko PJ, Lee Y-H, Makhey V, Leesman GD, Sutyak JP, Yu H, Perry B, Smith CL, Hu P, Wagner EJ, Falzone LM, McWhorter LT, Gilligan JP, Stern W. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: In vitro permeability and in vivo oral absorption of salmon calcitonin (sCT). Pharm Res 1999; 16(4)527–533
   PubMed Web of Science ®Google Scholar
• Swarbrick J, Boylan JC. Encyclopedia of pharmaceutical Technology2nd ed. Marcel Dekker Inc, New York 2002
   Google Scholar
• Woodley JF. Enzymatic Barriers for GI Peptide and Protein Delivery. Crit Rev Ther Drug Carrier Syst 1994; 11(2–3)61–95
   PubMed Web of Science ®Google Scholar
• Yamamoto A. Improvement of transmucosal absorption of biologically active peptide drugs. Yakugaku Zasshi 2001; 121(12)929–948
   PubMed Web of Science ®Google Scholar